Streetbeat News

Earnings

FRPT

Freshpet Inc (NASDAQ:FRPT) reported a significant increase in its fourth-quarter fiscal 2023 sales, with a 29.9% year-on-year growth to $215.42 million, surpassing the consensus of $204.36 million. The company's EPS was $0.31, greatly exceeding the consensus of $0.05. Gross profit, adjusted gross profit, and net income saw substantial increases, with adjusted EBITDA rising by 66.9% year-on-year. Freshpet also reported positive net cash flows and holds $297.87 million in cash and equivalents. For 2024, Freshpet expects net sales of at least $950 million and projects an adjusted gross margin expansion and adjusted EBITDA of $100 million to $110 million. Following the report, FRPT shares surged by 17.28% to $107.91.

Portfolio Pulse from Akanksha Bakshi

February 26, 2024 | 4:14 pm

DKL

Delek Logistics Partners (NYSE:DKL) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $0.89. The company's past earnings performance shows mixed results, with a slight beat last quarter but a subsequent 2.0% drop in share price. Over the last year, DKL shares have declined by 10.04%, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:02 pm

FOUR

Shift4 Payments (NYSE:FOUR) is anticipated to report an EPS of $0.82 in its upcoming quarterly earnings on 2024-02-27. Historical data shows positive stock price reactions to earnings beats. Shares are currently trading at $75.01, with a 14.12% increase over the last 52 weeks. Investors are advised to watch for the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:02 pm

OSUR

OraSure Technologies (NASDAQ:OSUR) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts predicting an EPS of $0.08. The company's past performance shows a history of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $6.96, reflecting a 10.38% increase over the last 52 weeks. Investors are optimistic but will be closely watching the guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:02 pm

PRCT

PROCEPT BioRobotics (NASDAQ:PRCT) is scheduled to release its quarterly earnings report on February 27, 2024, with an estimated EPS of $-0.44. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows that PRCT's stock price reacts significantly to earnings performance and guidance. Last quarter, PRCT beat the EPS estimate, resulting in an 18.37% stock price increase the following day. Over the last year, PRCT shares have risen by 33.56%, indicating a positive trend for long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm

MYGN

Myriad Genetics (NASDAQ:MYGN) is expected to report an EPS of $0.01 in its upcoming quarterly earnings on 2024-02-27. Historically, the company has had mixed earnings performance but has shown a positive trend in stock price over the last 52 weeks, with a 20.35% increase. Investors are looking for not just an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm

XNCR

Xencor (NASDAQ:XNCR) is scheduled to release its quarterly earnings report on February 27, 2024, with an estimated EPS of $-0.09. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for the next quarter. Xencor's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 7.01% drop. Shares are currently trading at $24.47, down 21.16% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm

ALEC

Alector (NASDAQ:ALEC) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-0.77. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat leading to a 7.3% drop. Alector's shares have decreased by 22.72% over the last 52 weeks, indicating a generally negative sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm

SSRM

SSR Mining (NASDAQ:SSRM) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $0.33. The company's past earnings performance shows mixed results, with a slight miss last quarter leading to a 1.79% drop in share price. SSR Mining's stock has declined 66.41% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm

SNDX

Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to release its quarterly earnings report on February 27, 2024, with an expected EPS of $-0.99. Investors are hopeful for a beat on this estimate and positive future guidance. Historically, SNDX's stock price has shown mixed reactions to past earnings, with a slight overall decline of 5.92% over the last year. The company's past performance includes beating the EPS estimate last quarter, which led to a minor share price increase of 0.14% the following day.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:01 pm